Back to Search
Start Over
Supplemental Figure 1 from MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent In Vitro and In Vivo Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- MLN0128 inhibits pAKT T308 in MPNST and ST8814 cell lines AND Only MLN0128 but not rapamycin induces cleaved PARP in rhabdomyosarcoma cell lines
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....33761704190442466ada6c669b919e84
- Full Text :
- https://doi.org/10.1158/1535-7163.22502713